Treatment for Periodontal Disease in Dialysis Patients
KPU
Impact of Periodontal Therapy on Metabolic and Inflammatory Markers in Chronic Kidney Disease Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The primary objective is to test the hypothesis that periodontal intervention in dialysis patients who have both periodontal disease and a historically high burden of cardiovascular disease will result in a reduction of inflammatory markers and improvement markers of nutrition health like albumin. Patients will be randomized to one of two treatment arms: intensive periodontal therapy or control-delayed periodontal therapy. Eligible patients will have 5 study visits over 7 to 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 9, 2009
CompletedFirst Posted
Study publicly available on registry
July 13, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedMay 7, 2012
May 1, 2012
1.8 years
July 9, 2009
May 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum Albumin, IL-6, CRP
6 months
Secondary Outcomes (1)
HbA1c, periodontal probing
6 months
Study Arms (2)
Control-delayed periodontal therapy
OTHERIntensive Periodontal Therapy
OTHERInterventions
Participants will take antibiotics prior to dental treatment. Periodontal treatment or a deep cleaning (with local anesthesia or numbing) will be performed to remove plaque and tartar around the teeth and gums. A small amount of antibiotics (minocycline) will be placed around the gums to help fight bacteria and inflammation.
Eligibility Criteria
You may qualify if:
- Presence of 12 or more teeth
- Presence of moderate to severe periodontal disease (2 or more teeth with at least 6 mm Clinical Attachment Loss and at least 1 site with Probing Depth \> 5 mm)
- Receiving dialysis for at least 3 months
- English speaking
- Ability and willingness to give written informed consent for participation in the study
- Age 18 to 80 years
- Twelve or more teeth
You may not qualify if:
- Any severe co-morbid conditions likely to affect life expectancy within 1 year (for example, metastatic cancer)
- Any condition that would, in the judgement of the clinician, be a contraindication to dental treatment
- Dementia
- Pregnancy or lactation
- Inability to take oral medications
- Allergy or intolerance to minocycline, tetracyclines or polygycolate polymers
- Allergy to both penicillin and clindamycin
- Severe dental caries, pulpal or mucosal disease that would interfere with periodontal therapy
- Inability or unwillingness to follow the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- OraPharmacollaborator
Study Sites (1)
GO Health Center, School of Dentistry, University of North Carolina-Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Publications (1)
Wehmeyer MM, Kshirsagar AV, Barros SP, Beck JD, Moss KL, Preisser JS, Offenbacher S. A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study. Am J Kidney Dis. 2013 Mar;61(3):450-8. doi: 10.1053/j.ajkd.2012.10.021. Epub 2012 Dec 20.
PMID: 23261122DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Offenbacher, DDS, PhD
UNC Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DDS
Study Record Dates
First Submitted
July 9, 2009
First Posted
July 13, 2009
Study Start
August 1, 2008
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
May 7, 2012
Record last verified: 2012-05